The Global Health Body Sounds Concern Over Critical Shortage of Obesity Injections

Less than 10% of people who could benefit from obesity jabs such as Wegovy are able to get them, states the World Health Organization as it releases its initial advice on the drugs.

With in excess of 1,000,000,000 individuals worldwide now classified as obese, it is advocating for broader and more equitable access to these injectable treatments.

According to forecasts, more than two billion are projected to be living with obesity by 2030 unless action is taken.

"The latest guidelines recognises that obesity is a chronic disease that can be treated with holistic and ongoing care," remarked WHO director-general Tedros Adhanom Ghebreyesus.

High costs, insufficient output, and supply-chain constraints are key hurdles to widespread access to the injections that can assist patients in reducing considerable body mass, notes the organization.

GLP-1 Therapy Supply Crisis

Despite the current most optimistic case, the supply of these medications might only reach about 100 million people – fewer than 10% of the global need, per the health organization.

The advice urges countries and companies to widen availability, by approaches such as licensing agreements.

Exclusive production rights on semaglutide – the main component of Novo Nordisk's Wegovy – is scheduled to end in several nations in 2026.

The Way Weight-Loss Drugs Operate

The injections imitate a biological compound to slow digestion, curb appetite and boost feelings of fullness so people eat less.

Individuals commonly see weight reduction in the initial weeks of beginning the weekly injections.

Evidence indicates patients may put most of the weight back on within a year of halting the treatment, as their normal food cravings come back.

To be overweight or obese raises your likelihood for contracting health problems, such as type 2 diabetes, cardiovascular issues, brain attack, and specific malignancies.

Excess weight affects people in countries worldwide and was associated with over three and a half million deaths worldwide in 2024, per the health agency.